Home > Services > Advanced Biological Therapy Unit - PRP

Advanced Biological Therapy Unit - PRP

Advanced Biological Therapy Unit - PRP Advanced Biological Therapy Unit - PRP Advanced Biological Therapy Unit - PRP

Advanced Biological Therapy Unit - PRP

The Advanced Biological Therapy Unit (UTBA) at the MiKS  Hospital is the service where biological treatments are carried out, especially using platelet-rich plasma (PRP). This biomedical technique harnesses the body’s own components to activate the repair of damaged tissues and promote their regeneration. In this context, the patient’s own blood is used as the basis of the treatment, since PRP is obtained from an autologous sample for subsequent therapeutic application.

Procedures at the UTBA are performed on an outpatient basis within the hospital setting, allowing all stages of the process to be managed in a single location: blood collection, PRP preparation, and administration. This ensures strict compliance with asepsis protocols, safety standards, continuous medical follow-up, and full traceability, while adapting each treatment to the individual needs of the patient.

In certain cases, ultrasound-guided infiltrations are used, in coordination between the traumatology and radiology departments. This technique enables more precise application of PRP to the injured area, which may improve outcomes in complex conditions.

In this way, through biological therapies and minimally invasive image-guided procedures, it is possible to treat injuries in joints, bones, tendons, muscles, and other tissues.

The Advanced Biological Therapy Unit operates under a translational medicine model, in which daily clinical practice and scientific research progress together. The goal is for every advance in knowledge to be directly translated into real benefits for patients. This combination of science, clinical experience, and continuous monitoring allows treatments to be constantly improved, offering increasingly precise, safe, and effective regenerative medicine, with therapies adapted according to each patient, their condition, clinical protocols, and the dosage or therapeutic regimen used.